Skip to content

Prevention of benign endometrial polyp recurrence using Mirena device in premenopausal women.

Prevention of benign endometrial polyp recurrence using a levonorgestrel releasing intrauterine device in premenopausal women.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900023207
Enrollment
Unknown
Registered
2019-05-16
Start date
2019-06-01
Completion date
Unknown
Last updated
2019-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial Polyp

Interventions

Mirena:Insert Mirena
Control:No IUD insertion

Sponsors

Institute of Translational Medicine, Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
16 Years to 50 Years

Inclusion criteria

Inclusion criteria: (1) Premenopausal women, the last menstrual period is <1 year from the day of surgery; (2) Factor endometrial polyps were performed in hysteroscopic endometrial polypectomy in our hospital day center; (3) Postoperative pathological diagnosis of benign endometrial polyps; (4) Surgery from January 1, 2016 to December 31, 2017.

Exclusion criteria

Exclusion criteria: (1) Accepting hormone therapy, including Tamoxifen; (2) Diagnosed as hyperplasia polyps; (3) Obesity(BMI?28kg/m2), diabetes or hypertension; (4) Diagnosed as PCOS, endometriosis, leiomyoma or infertility; (5) participated in other clinical trails; (6) Patients without follow-up conditions after surgery; (7) Any conditions concerned with IUD, such as IUD disengagement, displacement or taken out; Any conditions concerned with pregnancy, such as conception, miscarriage or ectopic pregnancy; patients lost to follow-up, or used other drugs or treatments interfering with the level of reproductive hormones in the body; (8) The investigators believe that there are other reasons not suitable for clinical trials.

Design outcomes

Primary

MeasureTime frame
Endometrial Polyp;

Countries

China

Contacts

Public ContactYe Feng

Women's Hospital, Zhejiang University School of Medicine

pandafengye@zju.edu.cn+86 13588193918

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026